BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, Tuzzolino F, Gridelli B, Bosch J. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60:846-852. [PMID: 21357252 DOI: 10.1136/gut.2010.228023] [Cited by in Crossref: 168] [Cited by in F6Publishing: 135] [Article Influence: 16.8] [Reference Citation Analysis]
Number Citing Articles
1 Gaba RC, Parvinian A. Transjugular intrahepatic portosystemic shunt for maintenance of portal venous patency in liver transplant candidates. J Clin Imaging Sci 2013;3:28. [PMID: 24083066 DOI: 10.4103/2156-7514.115761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Mancuso A. Management of portal vein thrombosis in cirrhosis: an update. Eur J Gastroenterol Hepatol. 2016;28:739-743. [PMID: 27075588 DOI: 10.1097/meg.0000000000000633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Role of band ligation for secondary prophylaxis of variceal bleeding. World J Gastroenterol. 2018;24:2902-2914. [PMID: 30018485 DOI: 10.3748/wjg.v24.i26.2902] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology. 2016;278:333-353. [PMID: 26789601 DOI: 10.1148/radiol.2015141858] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
5 Pardo F, Pons JA, Briceño J. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante. Cirugía Española 2015;93:619-37. [DOI: 10.1016/j.ciresp.2015.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Qi X, Han G, He C, Yin Z, Zhang H, Wang J, Xia J, Cai H, Yang Z, Bai M, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit 2012;18:HY37-41. [PMID: 22847208 DOI: 10.12659/msm.883252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ma J, Yan Z, Luo J, Liu Q, Wang J, Qiu S. Rational classification of portal vein thrombosis and its clinical significance. PLoS One. 2014;9:e112501. [PMID: 25393320 DOI: 10.1371/journal.pone.0112501] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
8 Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G;  PVT-TIPS Study Group. Covered TIPS vs endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut. 2018;67:2156-2168. [PMID: 28970291 DOI: 10.1136/gutjnl-2017-314634] [Cited by in Crossref: 61] [Cited by in F6Publishing: 44] [Article Influence: 15.3] [Reference Citation Analysis]
9 Congly SE, Lee SS. Portal vein thrombosis: should anticoagulation be used? Curr Gastroenterol Rep. 2013;15:306. [PMID: 23314804 DOI: 10.1007/s11894-012-0306-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
10 Wang CM, Li X, Fu J, Luan JY, Li TR, Zhao J, Dong GX. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis. Chin Med J (Engl) 2016;129:1261-7. [PMID: 27231160 DOI: 10.4103/0366-6999.182830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
11 Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013;58:1776-1780. [PMID: 23314858 DOI: 10.1007/s10620-012-2548-y] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 11.1] [Reference Citation Analysis]
12 Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis. 2017;49:113-120. [PMID: 27965037 DOI: 10.1016/j.dld.2016.11.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
13 Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021. [PMID: 34323378 DOI: 10.1111/1751-2980.13035] [Reference Citation Analysis]
14 Intagliata NM, Argo CK, Stine JG, Lisman T, Caldwell SH, Violi F; faculty of the 7th International Coagulation in Liver Disease. Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference. Thromb Haemost. 2018;118:1491-1506. [PMID: 30060258 DOI: 10.1055/s-0038-1666861] [Cited by in Crossref: 69] [Cited by in F6Publishing: 53] [Article Influence: 23.0] [Reference Citation Analysis]
15 Peck-Radosavljevic M, Angeli P, Cordoba J, Farges O, Valla D. Managing complications in cirrhotic patients. United European Gastroenterol J 2015;3:80-94. [PMID: 25653862 DOI: 10.1177/2050640614560452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
16 Luo X, Wang Z, Tsauo J, Zhou B, Zhang H, Li X. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS vs Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding. Radiology. 2015;276:286-293. [PMID: 25759969 DOI: 10.1148/radiol.15141252] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
17 Ni JB, Xiang XX, Wu W, Chen SY, Zhang F, Zhang M, Peng CY, Xiao JQ, Zhuge YZ, Zhang CQ. Transjugular intrahepatic portosystemic shunt in patients treated with a balloon tamponade for variceal hemorrhage without response to high doses of vasoactive drugs: A real-world multicenter retrospective study. J Dig Dis 2021;22:236-45. [PMID: 33634958 DOI: 10.1111/1751-2980.12978] [Reference Citation Analysis]
18 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int. 2012;6:576-590. [PMID: 26201472 DOI: 10.1007/s12072-011-9324-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
19 Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, Turco L, Dragoni G, Laffi G, Marra F. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. [DOI: 10.1007/s11739-019-02252-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
20 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Buechter M, Manka P, Gerken G, Canbay A, Blomeyer S, Wetter A, Altenbernd J, Kahraman A, Theysohn JM. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience. Dig Dis 2018;36:218-27. [PMID: 29316565 DOI: 10.1159/000486030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
22 Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015;99:2347-2355. [PMID: 25905983 DOI: 10.1097/tp.0000000000000729] [Cited by in Crossref: 78] [Cited by in F6Publishing: 15] [Article Influence: 15.6] [Reference Citation Analysis]
23 Qi X, He C, Yin Z, Wang Z, Zhang H, Yao L, Wang J, Xia J, Cai H, Yang Z, Bai M, Guo W, Niu J, Wu K, Fan D, Han G; PVT-TIPS Study Group. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open 2013;3:e003370. [PMID: 23847271 DOI: 10.1136/bmjopen-2013-003370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Cao G, Ko GY, Sung KB, Yoon HK, Gwon DI, Kim JH. Treatment of postoperative main portal vein and superior mesenteric vein thrombosis with balloon angioplasty and/or stent placement. Acta Radiol. 2013;54:526-532. [PMID: 23463860 DOI: 10.1177/0284185113475917] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
25 Rosenqvist K, Eriksson L, Rorsman F, Sangfelt P, Nyman R. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver. Acta Radiol 2016;57:572-9. [DOI: 10.1177/0284185115595060] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
26 Seijo S, García-criado Á, Darnell A, García-pagán JC. Diagnóstico y tratamiento de la trombosis portal en la cirrosis hepática. Gastroenterología y Hepatología 2012;35:660-6. [DOI: 10.1016/j.gastrohep.2012.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
27 Liu L, Zhao Y, Qi X, Cai G, He C, Guo W, Yin Z, Chen H, Chen X, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res. 2014;44:621-630. [PMID: 23679937 DOI: 10.1111/hepr.12162] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
28 Nicoară-Farcău O, Soy G, Magaz M, Baiges A, Turon F, Garcia-Criado A, Barrufet M, Burrel M, Hernández-Gea V, García-Pagán JC. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:673-81. [PMID: 32820481 DOI: 10.1055/s-0040-1715473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
29 Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol. 2015;21:6769-6784. [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 27] [Article Influence: 9.2] [Reference Citation Analysis]
30 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 54] [Article Influence: 39.5] [Reference Citation Analysis]
31 Benten D, Schulze zur Wiesch J, Sydow K, Koops A, Buggisch P, Böger RH, Gaydos CA, Won H, Franco V, Lohse AW, Ray SC, Balagopal A. The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS). BMC Gastroenterol 2011;11:107. [PMID: 21978390 DOI: 10.1186/1471-230X-11-107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
32 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 132] [Cited by in F6Publishing: 32] [Article Influence: 14.7] [Reference Citation Analysis]
34 Wan YM, Li YH, Xu ZY, Wu HM, Wu XN, Xu Y. Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding. Eur Radiol 2019;29:5032-41. [PMID: 30796573 DOI: 10.1007/s00330-019-06046-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Vasconcelos-filho JM, Pereira AH, Pitta GBB, Leitão-batista L, Castro AA, Souza-leão AR, Lacerda CM. Measurements between the hepatic veins and portal venous system, in human cirrhotic liver: a cast study. Surg Radiol Anat 2018;40:395-400. [DOI: 10.1007/s00276-017-1909-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017;9:603-12. [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Valentin N, Korrapati P, Constantino J, Young A, Weisberg I. The role of transjugular intrahepatic portosystemic shunt in the management of portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2018;30:1187-93. [PMID: 30074506 DOI: 10.1097/MEG.0000000000001219] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 11.5] [Reference Citation Analysis]
38 Allaire M, Walter A, Sutter O, Nahon P, Ganne-carrié N, Amathieu R, Nault J. TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2020;44:249-63. [DOI: 10.1016/j.clinre.2019.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
39 Sharshar M, Yagi S, Iida T, Yao S, Miyachi Y, Macshut M, Iwamura S, Hirata M, Ito T, Hata K, Taura K, Okajima H, Kaido T, Uemoto S. Liver transplantation in patients with portal vein thrombosis: A strategic road map throughout management. Surgery 2020;168:1160-8. [PMID: 32861438 DOI: 10.1016/j.surg.2020.07.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC. Transient portal vein thrombosis in liver cirrhosis. BMC Med 2018;16:83. [PMID: 29871683 DOI: 10.1186/s12916-018-1069-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
41 Primignani M, Tosetti G, La Mura V. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol 2015;7:2906-12. [PMID: 26689354 DOI: 10.4254/wjh.v7.i29.2906] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
42 Young K, Wong R. Evaluation and management of acute and chronic portal vein thrombosis in patients with cirrhosis. Clin Liver Dis (Hoboken) 2017;10:152-6. [PMID: 30992777 DOI: 10.1002/cld.679] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
43 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017;5:148-56. [PMID: 28533912 DOI: 10.1093/gastro/gox014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
44 Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. J Vasc Interv Radiol. 2015;26:1257-65; quiz 1265. [PMID: 25990133 DOI: 10.1016/j.jvir.2015.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
45 Merola J, Fortune BE, Deng Y, Ciarleglio M, Amirbekian S, Chaudhary N, Shanbhogue A, Ayyagari R, Rodriguez-Davalos MI, Teperman L, Charles HW, Sigal SH. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis. Eur J Gastroenterol Hepatol 2018;30:668-75. [PMID: 29462027 DOI: 10.1097/MEG.0000000000001097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
46 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
47 Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW. Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. Transplant Rev (Orlando). 2014;28:92-101. [PMID: 24582320 DOI: 10.1016/j.trre.2014.01.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
48 Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2016;28:82-89. [PMID: 26513611 DOI: 10.1097/meg.0000000000000482] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
49 Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol. 2012;18:5211-5218. [PMID: 23066315 DOI: 10.3748/wjg.v18.i37.5211] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
50 Senzolo M, Garcia-Tsao G, García-Pagán JC. Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol 2021;75:442-53. [PMID: 33930474 DOI: 10.1016/j.jhep.2021.04.029] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Valla DC, Cazals-Hatem D. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Arch. 2018;473:3-13. [PMID: 29572606 DOI: 10.1007/s00428-018-2331-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
52 Barbier CE, Rorsman F, Eriksson LG, Sangfelt P, Sheikhi R, Vessby J, Nyman R. Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions - a retrospective evaluation. Acta Radiol Open 2020;9:2058460120964074. [PMID: 33110628 DOI: 10.1177/2058460120964074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol. 2014;11:435-446. [PMID: 24686266 DOI: 10.1038/nrgastro.2014.36] [Cited by in Crossref: 82] [Cited by in F6Publishing: 66] [Article Influence: 11.7] [Reference Citation Analysis]
54 Qi X, Chen H, Han G. Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis. Am J Med Sci 2013;346:38-44. [PMID: 23187296 DOI: 10.1097/MAJ.0b013e31826485fc] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
55 Jiang TT, Luo XP, Sun JM, Gao J. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol. 2017;23:7470-7477. [PMID: 29151701 DOI: 10.3748/wjg.v23.i41.7470] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
56 Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int. 2016;36:667-676. [PMID: 26235541 DOI: 10.1111/liv.12929] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
57 Knight GM, Clark J, Boike JR, Maddur H, Ganger DR, Talwar A, Riaz A, Desai K, Mouli S, Hohlastos E, Garcia Pagan JC, Gabr A, Stein B, Lewandowski R, Thornburg B, Salem R. TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care Therapy. Hepatology 2021. [PMID: 34021505 DOI: 10.1002/hep.31915] [Reference Citation Analysis]
58 Fagiuoli S, Bruno R, Debernardi Venon W, Schepis F, Vizzutti F, Toniutto P, Senzolo M, Caraceni P, Salerno F, Angeli P, Cioni R, Vitale A, Grosso M, De Gasperi A, D'Amico G, Marzano A;  AISF TIPS Special Conference. Consensus conference on TIPS management: Techniques, indications, contraindications. Dig Liver Dis. 2017;49:121-137. [PMID: 27884494 DOI: 10.1016/j.dld.2016.10.011] [Cited by in Crossref: 52] [Cited by in F6Publishing: 33] [Article Influence: 10.4] [Reference Citation Analysis]
59 Sharma AM, Zhu D, Henry Z. Portal vein thrombosis: When to treat and how? Vasc Med. 2016;21:61-69. [PMID: 26584887 DOI: 10.1177/1358863x15611224] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
60 Lakhoo J, Gaba RC. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis. Diagn Interv Imaging. 2016;97:1085-1093. [PMID: 27481577 DOI: 10.1016/j.diii.2016.07.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
61 Luca A, Miraglia R, Maruzzelli L, D’amico M, Tuzzolino F. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors. Radiology 2016;280:622-9. [DOI: 10.1148/radiol.2016151625] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
62 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 54] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
63 Wan YM, Li YH, Wu HM, Xu ZY, Xu Y, Yang LH, Wu XN, Yang JH. Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant). Medicine (Baltimore) 2017;96:e8498. [PMID: 29137043 DOI: 10.1097/MD.0000000000008498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Hidaka H, Kokubu S, Sato T, Katsushima S, Izumi N, Igura T, Asahara S, Notsumata K, Osaki Y, Tsuji K, Kawanaka H, Akahoshi T, Hirota S, Matsutani S; NPB-06 study group. Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial. Hepatol Res 2018;48:E107-16. [PMID: 28666312 DOI: 10.1111/hepr.12934] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
65 Zhang DL, Hao JY, Yang N. Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis. J Int Med Res. 2013;41:664-672. [PMID: 23637275 DOI: 10.1177/0300060513483413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
66 Trebicka J. Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close? J Hepatol. 2017;66:442-450. [PMID: 27984174 DOI: 10.1016/j.jhep.2016.10.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 9.6] [Reference Citation Analysis]
67 Delgado MG, Seijo S, Yepes I, Achécar L, Catalina MV, García-Criado A, Abraldes JG, de la Peña J, Bañares R, Albillos A, Bosch J, García-Pagán JC. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012;10:776-83. [PMID: 22289875 DOI: 10.1016/j.cgh.2012.01.012] [Cited by in Crossref: 232] [Cited by in F6Publishing: 182] [Article Influence: 25.8] [Reference Citation Analysis]
68 Wang L, He F, Yue Z, Zhao H, Fan Z, Zhao M, Qiu B, Yao J, Lin Q, Dong X, Liu F. Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein. Sci Rep. 2017;7:10868. [PMID: 28883536 DOI: 10.1038/s41598-017-11455-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
69 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
70 Hibi T, Nishida S, Levi DM, Selvaggi G, Tekin A, Fan J, Ruiz P, Tzakis AG. When and why portal vein thrombosis matters in liver transplantation: A critical audit of 174 cases. Ann Surg. 2014;259:760-766. [PMID: 24299686 DOI: 10.1097/sla.0000000000000252] [Cited by in Crossref: 100] [Cited by in F6Publishing: 22] [Article Influence: 14.3] [Reference Citation Analysis]
71 Sun XY, Wang GC, Wang J, Huang GJ, Zhang CQ. Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding. Hepatobiliary Pancreat Dis Int 2021;20:128-36. [PMID: 33455864 DOI: 10.1016/j.hbpd.2020.12.016] [Reference Citation Analysis]
72 Stravitz RT. Thrombosis and coagulopathy in the liver transplant candidate and recipient. Clin Liver Dis (Hoboken) 2017;9:11-7. [PMID: 30992949 DOI: 10.1002/cld.606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Chen SL, Hu P, Lin ZP, Zhao JB. The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy. Gastroenterol Res Pract. 2019;2019:2935498. [PMID: 30728835 DOI: 10.1155/2019/2935498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
74 Luo X, Nie L, Zhou B, Yao D, Ma H, Jiang M, Zhang H, Li X. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma. Gastroenterol Res Pract 2014;2014:659726. [PMID: 24868203 DOI: 10.1155/2014/659726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
75 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol. 2012;57:203-212. [PMID: 22446690 DOI: 10.1016/j.jhep.2011.12.034] [Cited by in Crossref: 133] [Cited by in F6Publishing: 103] [Article Influence: 14.8] [Reference Citation Analysis]
76 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol. 2014;20:6470-6480. [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
77 Leonardi F, Maria N, Villa E. Anticoagulation in cirrhosis: a new paradigm? Clin Mol Hepatol. 2017;23:13-21. [PMID: 28288507 DOI: 10.3350/cmh.2016.0110] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 8.8] [Reference Citation Analysis]
78 Rodrigues SG, Sixt S, Abraldes JG, De Gottardi A, Klinger C, Bosch J, Baumgartner I, Berzigotti A. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther. 2019;49:20-30. [PMID: 30450634 DOI: 10.1111/apt.15044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
79 Maruyama H, Takahashi M, Shimada T, Yokosuka O. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding. Scand J Gastroenterol. 2012;47:686-691. [PMID: 22472055 DOI: 10.3109/00365521.2012.674972] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
80 Li YH, Xu ZY, Wu HM, Yang LH, Xu Y, Wu XN, Wan YM. Long-term shunt patency and overall survival of transjugular intrahepatic portosystemic shunt placement using covered stents with bare stents versus covered stents alone. Clin Radiol. 2018;73:580-587. [PMID: 29475551 DOI: 10.1016/j.crad.2018.01.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
81 Rössle M MD, Schultheiss M. Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective. J Transl Int Med 2018;6:11-5. [PMID: 29607298 DOI: 10.2478/jtim-2018-0003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
82 Yue-Meng W, Li YH, Wu HM, Yang J, Yang LH, Xu Y. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes. Clin Appl Thromb Hemost 2018;24:462-70. [PMID: 28110540 DOI: 10.1177/1076029616689593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
83 Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein. Hepatobiliary Pancreat Dis Int. 2018;17:517-523. [PMID: 30262421 DOI: 10.1016/j.hbpd.2018.09.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
84 Albillos A, Tejedor M. Secondary prophylaxis for esophageal variceal bleeding. Clin Liver Dis 2014;18:359-70. [PMID: 24679500 DOI: 10.1016/j.cld.2014.01.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
85 Stotts MJ, Wentworth BJ, Northup PG. Management of Portal Vein Thrombosis in Cirrhosis. Semin Liver Dis 2021;41:79-86. [PMID: 33764487 DOI: 10.1055/s-0040-1722260] [Reference Citation Analysis]
86 Cui SB, Shu RH, Yan SP, Wu H, Chen Y, Wang L, Zhu Q. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B. Eur J Gastroenterol Hepatol. 2015;27:914-919. [PMID: 25856686 DOI: 10.1097/meg.0000000000000351] [Cited by in Crossref: 50] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
87 Schultheiß M, Bettinger D, Thimme R, Rössle M. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Z Gastroenterol 2020;58:877-89. [DOI: 10.1055/a-1217-7866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Bissonnette J, Garcia-Pagán JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, Sibert A, Bouchard L, Perreault P, Trebicka J, Trottier-Tellier F, Rautou PE, Valla DC, Plessier A. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology 2016;64:224-31. [PMID: 26990687 DOI: 10.1002/hep.28547] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
89 Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci 2017;3. [PMID: 30221012 DOI: 10.15761/JTS.1000182] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
90 Mancuso A. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation. Curr Hepatology Rep 2017;16:158-63. [DOI: 10.1007/s11901-017-0344-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
91 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
92 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 291] [Cited by in F6Publishing: 179] [Article Influence: 48.5] [Reference Citation Analysis]
93 Zhang JB, Chen J, Zhou J, Wang XM, Chen S, Chu JG, Liu P, Ye ZD. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis. World J Clin Cases 2021;9:5179-90. [PMID: 34307565 DOI: 10.12998/wjcc.v9.i19.5179] [Reference Citation Analysis]
94 Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC. Hypercoagulability in cirrhosis: causes and consequences1: Hypercoagulability in cirrhosis. Journal of Thrombosis and Haemostasis 2011;9:1713-23. [DOI: 10.1111/j.1538-7836.2011.04429.x] [Cited by in Crossref: 164] [Cited by in F6Publishing: 125] [Article Influence: 16.4] [Reference Citation Analysis]
95 Simonetto DA, Singal AK, Garcia-Tsao G, Caldwell SH, Ahn J, Kamath PS. ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation. Am J Gastroenterol. 2020;115:18-40. [PMID: 31895720 DOI: 10.14309/ajg.0000000000000486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
96 Lv Y, Li K, He C, Luo B, Zhang B, Liu H, Wang Z, Guo W, Wang Q, Chen H, Bai W, Yuan X, Yu T, Li X, Yuan J, Han N, Zhu Y, Niu J, Xie H, Wang J, Chen L, Yin Z, Fan D, Li Z, Han G. TIPSS for variceal bleeding in patients with idiopathic non-cirrhotic portal hypertension: comparison with patients who have cirrhosis. Aliment Pharmacol Ther. 2019;49:926-939. [PMID: 30820990 DOI: 10.1111/apt.15186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
97 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol. 2019;25:4437-4451. [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
98 Rössle M, Bausch B, Klinger C. Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View. Viszeralmedizin 2014;30:401-8. [PMID: 26288607 DOI: 10.1159/000370053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
99 Sharma A, Keshava SN, Eapen A, Elias E, Eapen CE. An Update on the Management of Budd-Chiari Syndrome. Dig Dis Sci 2021;66:1780-90. [PMID: 32691382 DOI: 10.1007/s10620-020-06485-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Stravitz RT. Algorithms for managing coagulation disorders in liver disease. Hepatol Int 2018;12:390-401. [PMID: 30066204 DOI: 10.1007/s12072-018-9886-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
101 Wang L, Xiao Z, Yue Z, Zhao H, Fan Z, Zhao M, He F, Dai S, Qiu B, Yao J, Lin Q, Dong X, Liu F. Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial. Sci Rep. 2016;6:21011. [PMID: 26876503 DOI: 10.1038/srep21011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
102 Smith M, Durham J. Evolving Indications for Tips. Tech Vasc Interv Radiol 2016;19:36-41. [PMID: 26997087 DOI: 10.1053/j.tvir.2016.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
103 Modaresi Esfeh J, Ansari-Gilani K. Transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol. 2020;32:762-763. [PMID: 32355095 DOI: 10.1097/meg.0000000000001680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Filì D, Falletta C, Luca A, Hernandez Baravoglia C, Clemenza F, Miraglia R, Scardulla C, Tuzzolino F, Vizzini G, Gridelli B, Bosch J. Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction. Digestive and Liver Disease 2015;47:1052-8. [DOI: 10.1016/j.dld.2015.08.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
105 D'Avola D, Bilbao JI, Zozaya G, Pardo F, Rotellar F, Iñarrairaegui M, Quiroga J, Sangro B, Herrero JI. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 2012;44:2603-5. [PMID: 23146469 DOI: 10.1016/j.transproceed.2012.09.050] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
106 Chinchilla-López P, Hamdan-Pérez N, Guerrero-Ixtlahuac J, Barranco-Fragoso B, Méndez-Sánchez N. The Role of TIPS in patients with Refractory Ascites and Portal Vein Thrombosis. Ann Hepatol 2017;16:619-20. [PMID: 28611269 DOI: 10.5604/01.3001.0010.0310] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Kiang SC, Rakoski MO, Tomihama RT. Retrograde Transvenous Obliteration Resolves Portal Vein Thrombosis without Systemic Anticoagulation. J Vasc Interv Radiol 2019;30:1631-3. [PMID: 31056451 DOI: 10.1016/j.jvir.2018.09.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Berzigotti A, García-criado Á, Darnell A, García-pagán J. Imaging in clinical decision-making for portal vein thrombosis. Nat Rev Gastroenterol Hepatol 2014;11:308-16. [DOI: 10.1038/nrgastro.2013.258] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 6.9] [Reference Citation Analysis]
109 Wang Z, Zhao H, Wang X, Zhang H, Jiang M, Tsauo J, Luo X, Yang L, Li X. Clinical outcome comparison between TIPS and EBL in patients with cirrhosis and portal vein thrombosis. Abdom Imaging. 2015;40:1813-1820. [PMID: 25504374 DOI: 10.1007/s00261-014-0320-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
110 Zhan C, Prabhu V, Kang SK, Li C, Zhu Y, Kim S, Olsen S, Jacobson IM, Dagher NN, Carney B, Hickey RM, Taslakian B. Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment. J Clin Med 2021;10:2316. [PMID: 34073236 DOI: 10.3390/jcm10112316] [Reference Citation Analysis]
111 Qi X, Valla DC, Guo X. Anticoagulation for Portal Vein Thrombosis in Cirrhosis: Selection of Appropriate Patients. Gastroenterology 2018;154:760-1. [PMID: 29351830 DOI: 10.1053/j.gastro.2017.09.057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
112 Qi X, Liu L, Bai M, Chen H, Wang J, Yang Z, Han G, Fan D. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. J Gastroenterol Hepatol. 2014;29:688-696. [PMID: 24117967 DOI: 10.1111/jgh.12391] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
113 Bhangui P, Fernandes ESM, Di Benedetto F, Joo DJ, Nadalin S. Current management of portal vein thrombosis in liver transplantation. Int J Surg 2020;82S:122-7. [PMID: 32387201 DOI: 10.1016/j.ijsu.2020.04.068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
114 Lombardo S, Espejo JJ, Pérez-Montilla ME, Zurera LJ, González-Galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiologia (Engl Ed) 2018;60:94-104. [PMID: 29122309 DOI: 10.1016/j.rx.2017.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
115 Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, Zhang L, Wang Q, Liu H, Luo B. Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis. Radiology. 2017;285:999-1010. [PMID: 28682164 DOI: 10.1148/radiol.2017162266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
116 Wang Z, Jiang MS, Zhang HL, Weng NN, Luo XF, Li X, Yang L. Is Post-TIPS Anticoagulation Therapy Necessary in Patients with Cirrhosis and Portal Vein Thrombosis? Radiology. 2016;279:943-951. [PMID: 26653681 DOI: 10.1148/radiol.2015150369] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 8.7] [Reference Citation Analysis]
117 Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol. 2015;25:3431-3437. [PMID: 25903717 DOI: 10.1007/s00330-015-3777-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
118 Mantaka A, Augoustaki A, Kouroumalis EA, Samonakis DN. Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges. Ann Gastroenterol 2018;31:315-29. [PMID: 29720857 DOI: 10.20524/aog.2018.0245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
119 Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y, Hashimoto N, Uehara H, Tomikawa M, Shirabe K, Maehara Y. Portal vein thrombosis in liver cirrhosis. World J Hepatol. 2014;6:64-71. [PMID: 24575165 DOI: 10.4254/wjh.v6.i2.64] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
120 Raja K, Jacob M, Asthana S. Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol 2014;4:320-31. [PMID: 25755579 DOI: 10.1016/j.jceh.2013.12.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
121 Sabol TP, Molina M, Wu GY. Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol 2015;3:189-94. [PMID: 26623265 DOI: 10.14218/JCTH.2015.00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Rössle M. TIPS: 25years later. Journal of Hepatology 2013;59:1081-93. [DOI: 10.1016/j.jhep.2013.06.014] [Cited by in Crossref: 184] [Cited by in F6Publishing: 141] [Article Influence: 23.0] [Reference Citation Analysis]
123 Mammen S, Keshava SN, Kattiparambil S. Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion. J Clin Exp Hepatol. 2015;5:259-261. [PMID: 26628844 DOI: 10.1016/j.jceh.2014.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
124 Klinger C, Riecken B, Schmidt A, De Gottardi A, Meier B, Bosch J, Caca K. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Digestive and Liver Disease 2017;49:1345-52. [DOI: 10.1016/j.dld.2017.05.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
125 Verbeek TA, Stine JG, Saner FH, Bezinover D. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplant Direct 2018;4:e403. [PMID: 30534594 DOI: 10.1097/TXD.0000000000000843] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 4.3] [Reference Citation Analysis]
126 Koo KS, Lamar DL, Shaw DW, Monroe EJ, Shivaram GM. Catheter-Directed Thrombolysis for Portal Vein Thrombosis in Children: A Case Series. Journal of Vascular and Interventional Radiology 2018;29:1578-83. [DOI: 10.1016/j.jvir.2018.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
127 Pieri G, Theocharidou E, Burroughs AK. Liver in haematological disorders. Best Practice & Research Clinical Gastroenterology 2013;27:513-30. [DOI: 10.1016/j.bpg.2013.06.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
128 Valla DC, Rautou PE. The coagulation system in patients with end-stage liver disease. Liver Int 2015;35 Suppl 1:139-44. [PMID: 25529099 DOI: 10.1111/liv.12723] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
129 Luca A, Caruso S, Milazzo M, Marrone G, Mamone G, Crinò F, Maruzzelli L, Miraglia R, Floridia G, Vizzini G. Natural Course of Extrahepatic Nonmalignant Partial Portal Vein Thrombosis in Patients with Cirrhosis. Radiology 2012;265:124-32. [DOI: 10.1148/radiol.12112236] [Cited by in Crossref: 107] [Cited by in F6Publishing: 78] [Article Influence: 11.9] [Reference Citation Analysis]
130 Poincloux L, Chabrot P, Mulliez A, Genes J, Boyer L, Abergel A. Interventional endoscopic ultrasound: A new promising way for intrahepatic portosystemic shunt with portal pressure gradient. Endosc Ultrasound 2017;6:394-401. [PMID: 29251274 DOI: 10.4103/eus.eus_42_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
131 Qiu B, Li K, Dong X, Liu FQ. Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Cardiovasc Intervent Radiol. 2017;40:1372-1382. [PMID: 28488102 DOI: 10.1007/s00270-017-1655-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
132 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
133 Zhao M, Yue Z, Zhao H, Wang L, Fan Z, He F, Yao J, Dong X, Liu F. Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis. Sci Rep. 2016;6:33069. [PMID: 27620282 DOI: 10.1038/srep33069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
134 Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9:936-946; quiz e123. [PMID: 21699820 DOI: 10.1016/j.cgh.2011.06.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
135 Dariushnia SR, Haskal ZJ, Midia M, Martin LG, Walker TG, Kalva SP, Clark TW, Ganguli S, Krishnamurthy V, Saiter CK, Nikolic B; Society of Interventional Radiology Standards of Practice Committee. Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts. J Vasc Interv Radiol. 2016;27:1-7. [PMID: 26614596 DOI: 10.1016/j.jvir.2015.09.018] [Cited by in Crossref: 65] [Cited by in F6Publishing: 40] [Article Influence: 10.8] [Reference Citation Analysis]